Other ingredients
Rice Flour; Gelatin; Magnesium Stearate (Mg Stearate); Titanium Dioxide (TiO2); FD&C Red #40
Image: NIH Office of Dietary Supplements, Dietary Supplement Label Database — No separate image reuse license stated
50CalLabz
Dole Proof
Capsule
Serving size3 Capsule(s)
Servings per containerNot listed
Package180 Capsule(s)
Data retrievedJul 28, 2026
Supplement Facts
Serving size 3 Capsule(s)
Vitamin D19 mcg95% DV
Zinc23 mg209% DV
Tribulus Fruit Extract1000 mgDV not established
Fadogia agrestis; Powder600 mgDV not established
Longjack Root Extract450 mgDV not established
Bulbine natalenis Aerial Parts Extract300 mgDV not established
Mucuna Seed Extract200 mgDV not established
3;3 Diindolylmethane200 mgDV not established
Boron15 mgDV not established
BioPerine5 mgDV not established
Label directions
Directions: Take (3) capsules twice daily with food.
Label warnings
Warning: Not for use of persons under the age of 18. Keep out of reach of children. Do not use if you are currently breast feeding pregnant or plan to become pregnant. Consult your doctor prior to use if you have any medical conditions or if you are taking any other medications. Discontinue use immediately if you experience rapid heartbeat dizziness vomiting or other similar symptoms. Do not exceed recommended dosage. Do not take longer than 12 weeks without a 4 week off period.
Identity and label version
NIH label record336367
Entered into NIH DSLDJun 25, 2025
UPC / GTIN00783495262817
Manufacturer / distributor on label50CalLabz LLC
Market statusOn market in the source data
“Entered into NIH DSLD” is the database entry date for this label record. It is not a manufacturer launch date or a label effective date.
NIH label history (1)
Current labelNIH record 336367Entered Jun 25, 2025
Vitamin D19 mcg
Zinc23 mg
Tribulus Fruit Extract1000 mg
Fadogia agrestis; Powder600 mg
Longjack Root Extract450 mg
Bulbine natalenis Aerial Parts Extract300 mg
Mucuna Seed Extract200 mg
3;3 Diindolylmethane200 mg
Boron15 mg
BioPerine5 mg
Label warning: Warning: Not for use of persons under the age of 18. Keep out of reach of children. Do not use if you are currently breast feeding pregnant or plan to become pregnant. Consult your doctor prior to use if you have any medical conditions or if you are taking any other medications. Discontinue use immediately if you experience rapid heartbeat dizziness vomiting or other similar symptoms. Do not exceed recommended dosage. Do not take longer than 12 weeks without a 4 week off period.
Sources and traceability
- NIH Dietary Supplement Label DatabaseData retrieved Jul 28, 2026Open source ↗
Data comes from product labels or official public sources. It does not mean Safmira, NIH, or FDA approves, certifies, or recommends this product. Label amounts are not laboratory measurements.